Australian headquartered Cardia Bioplastics announced that it is setting up its own film and bag manufacturing plant in São Paulo, Brazil. New purpose-built facilities have been leased and production commencement is scheduled for September 2014. The production machinery costing A$750,000 is funded using vendor finance over a twelve months period. The new factory is expected to deliver a production capacity of 500 million retail carry bags per year. This capacity is over four times greater than that of the current Cardia Bioplastics manufacturing plant in Nanjing, China.
Cathay Pacific Airways announced a strategic investment in Fulcrum BioEnergy, and negotiated a long-term supply agreement with Fulcrum for an initial 375 million US gallons of sustainable aviation fuel over 10 years (representing on an annual basis approximately 2% of the airline’s current fuel consumption) that meets all the airline’s technical requirements and specifications.
Genomatica, US industrial biotech company, announced that major nylon intermediates – including hexamethylenediamine, caprolactam and adipic acid (HMD, CPL and ADA) – are the focus of its third publicly-disclosed development program.
Genomatica is developing complete process technologies for the biobased production of these intermediates, which it will then license to major firms in the nylon value chain. These three chemicals, with a total market of over $18 billion per year, are used primarily in the production of nylon 6 and nylon 6,6, also referred to as the polyamides PA 6 and PA 6,6.
Genoa will be the Euro-mediterranean capital of the bioeconomy for a couple of days. The Italian Forum on Industrial Biotechnology and Bioeconomy (IFIB) goes to the wonderful city of North-Western Italy from 25 to 26 September 2014 at Palazzo della Borsa, which – built in 1912 and located in the city by the main Piazza De Ferrari – has been the seat of the old stock exchange. Continue reading →
M&G Chemicals announced that has entered into a Sino-foreign joint venture with Anhui Guozhen CO, Ltd. The new company – Anhui M&G Guozhen Green Refinery CO, Ltd – will employ Proesa technology licensed by Beta Renewables to convert 970,000-1,300,000 metric tons per year of agricultural residues into cellulosic ethanol, glycols and by-products such as lignin in Fuyang City (Anhui Province, PRC).
Tetra Pak U.S. released a new white paper examining the use of materials in packaging that can be regrown or replenished naturally as a solution to the planet’s growing resource scarcity and to sustain the future of the consumer packaged goods industry.
The Florida Institute for Commercialization of Public Research, a non-profit organization that works with the technology licensing and commercialization offices of Florida’s state universities, announced yesterday that it has finalized a funding agreement with US Bioplastics, an Orlando-based company that takes feedstock waste, paper production by-products, or other plant waste to practical use and then returns it to the environment without damaging the ecology.
Another brick towards the European Bioeconomy. The European Commission organises from 8 to 9 October in Turin the EU Bioeconomy Stakeholders Conference “From sectors to system, from concept to reality”.
Two years on from the launching of the EU’s Bioeconomy Strategy, Brussels in collaboration with the Italian Presidency analyses the achievements and the opportunities ahead in the two-day conference.
Headquarter of Royal DSM in Heerlen (The Netherlands)
Royal DSM, the global Life Sciences and Materials Sciences company, announces today it has reached agreement to acquire Aland (HK) Holding Limited, a Hong Kong-based company producing vitamin C in mainland China. Financial details will not be disclosed at this time. Subject to customary conditions, the transaction is expected to close in the next six to nine months.
“In order to be commercially successful it is essential to facilitate the introduction of innovative biobased products on the market. This means ensuring the implementation of the Priority Recommendations from the Lead Market Initiative, to boost the uptake of innovative biobased products on the European market. A good example from the US, in this respect, is the Biopreferred programme, which was established to ensure that US policy is aiding sustainable biobased industries to have a competitive edge through public procurement initiatives. Additionally, we need to foster investments through combined financing”. To say this – in this exclusive interview with Il Bioeconomista – is Nathalie Moll, Secretary General of EuropaBio, the European Association for Bioindustries. With Moll we discuss about bioeconomy in Europe and the next edition of EFIB, the European Forum for Industrial Biotechnology and Bio-based economy, which will take place in Reims (France) from 30 September to 2 October. “This years’s EFIB – says Moll – will provide the forum for dynamic discussion around the year’s biggest and best joint ventures, with high profile consumer brands. It will also provide a snapshot of how policy is being put into practice through the most significant developments in scale up of commercial biorefineries around the world”.
IL BIOECONOMISTA 